|
MRK
|
Merck & Company, Inc.
|
8.27%
|
US
|
NYSE
|
|
JNJ
|
Johnson & Johnson
|
7.92%
|
US
|
NYSE
|
|
GILD
|
Gilead Sciences, Inc.
|
7.75%
|
US
|
NASDAQ
|
|
AMGN
|
Amgen Inc.
|
7.62%
|
US
|
NASDAQ
|
|
BMY
|
Bristol-Myers Squibb Company
|
7.21%
|
US
|
NYSE
|
|
OGN
|
Organon & Co.
|
4.44%
|
US
|
NYSE
|
|
VTRS
|
Viatris Inc.
|
4.35%
|
US
|
NASDAQ
|
|
PBH
|
Prestige Brand Holdings, Inc.
|
4.29%
|
US
|
NYSE
|
|
IRWD
|
Ironwood Pharmaceuticals, Inc.
|
4.11%
|
US
|
NASDAQ
|
|
ABBV
|
AbbVie Inc.
|
4.10%
|
US
|
NYSE
|
|
PFE
|
Pfizer, Inc.
|
4.03%
|
US
|
NYSE
|
|
UTHR
|
United Therapeutics Corporation
|
3.91%
|
US
|
NASDAQ
|
|
CAH
|
Cardinal Health, Inc.
|
3.89%
|
US
|
NYSE
|
|
VRTX
|
Vertex Pharmaceuticals Incorporated
|
2.21%
|
US
|
NASDAQ
|
|
HZNP
|
Horizon Pharma, Inc.
|
1.92%
|
US
|
NASDAQ
|
|
SGEN
|
Seattle Genetics, Inc.
|
1.91%
|
US
|
NASDAQ
|
|
PRGO
|
Perrigo Company
|
1.91%
|
US
|
NYSE
|
|
EBS
|
Emergent Biosolutions, Inc.
|
1.88%
|
US
|
NYSE
|
|
JAZZ
|
Jazz Pharmaceuticals plc
|
1.86%
|
US
|
NASDAQ
|
|
ALKS
|
Alkermes plc
|
1.86%
|
US
|
NASDAQ
|